Amedisys Inc (AMED)
Gross profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | -2,630,493 | -2,600,707 | -2,599,216 | -2,597,365 | -2,571,326 | -2,542,732 | -2,511,903 | -2,467,911 | -2,430,093 | -2,415,002 | -2,402,895 | -2,343,958 | -2,310,479 | -2,263,259 | -2,208,075 | -2,215,564 | -2,184,019 | -3,564,027 | -2,974,625 | -2,382,989 |
| Revenue (ttm) | US$ in thousands | 2,236,382 | 2,227,658 | 2,229,409 | 2,234,331 | 2,223,199 | 1,671,704 | 1,667,201 | 1,111,979 | 573,337 | 567,158 | 15,793 | 33,153 | 518,223 | 1,014,511 | 1,507,022 | 1,979,978 | 1,955,633 | 1,889,333 | 1,810,011 | 1,726,487 |
| Gross profit margin | -117.62% | -116.75% | -116.59% | -116.25% | -115.66% | -152.10% | -150.67% | -221.94% | -423.85% | -425.81% | -15,214.94% | -7,070.12% | -445.85% | -223.09% | -146.52% | -111.90% | -111.68% | -188.64% | -164.34% | -138.03% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $-2,630,493K ÷ $2,236,382K
= -117.62%
Amedisys Inc.'s gross profit margin has shown relatively stable performance over the last eight quarters, hovering between 43.13% and 44.31%. This indicates that the company has been able to maintain a consistent level of profitability on its sales after accounting for the cost of goods sold. Overall, the trend suggests that Amedisys has been effectively managing its production and operational costs to preserve a healthy margin on its revenue. Additionally, it is notable that the company's margins have remained above 43%, indicating a healthy level of profitability in its core operations.
Peer comparison
Dec 31, 2023